Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Snipr Biome Aps has 4 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner and a distinct art unit, indicating complete separation across the active examination assignments.
RAHMAN, MASUDUR is the busiest examiner, with 1 pending matter. Counsel should manage the matters individually and compare them for shared biotechnology claim or disclosure issues without assuming common examiner treatment.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAHMAN, MASUDUR | 1 | 72.9% | +31.7% |
| GANGLE, BRIAN J | 1 | 76.8% | +14.6% |
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.4% |
| CHEN, STACY BROWN | 1 | 66.1% | +40.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763680 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | RAHMAN, MASUDUR | — |
| 18314755 | PHAGE AND TRANSDUCTION PARTICLES | VIVLEMORE, TRACY ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763680 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | RAHMAN, MASUDUR | — |
| 18294101 | MICROBIOTA ENGINEERING | GANGLE, BRIAN J | — |
| 18027847 | SYNTHETIC VIRUSES | CHEN, STACY BROWN | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1645 | 1 |
| 1638 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18763680 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | RAHMAN, MASUDUR | 1633 | §102§112 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18294101 | MICROBIOTA ENGINEERING | GANGLE, BRIAN J | 1645 | §112 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18314755 | PHAGE AND TRANSDUCTION PARTICLES | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Final Rejection | — | Pending | May 09, 2023 |
| 18027847 | SYNTHETIC VIRUSES | CHEN, STACY BROWN | 1672 | §112 | Final Rejection | — | Pending | Mar 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSnipr Biome Aps has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Masudur Rahman has the most, with 1 of Snipr Biome Aps's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
